Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
批准号:
9120960
负责人:
Cameron Robert Currie
金额:
$15.19万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
Actinobacteria classAnti-Bacterial AgentsAntibioticsAntifungal AgentsAntsBacteriaBioinformaticsBiological AssayBrazilCatalogingCatalogsCentral AmericaChagas DiseaseChemicalsCollaborationsCommunicable DiseasesEcologyEvolutionGeneral PractitionersGenomic approachGenomicsGeographic DistributionGoalsHealthHematopoietic NeoplasmsHumanInsectaInvertebratesLeishmaniasisMass Spectrum AnalysisMethodsMicrobeNatural ProductsParasitesPatternPharmaceutical PreparationsPhylogenetic AnalysisProductionResearchRibosomal RNASamplingSequence AnalysisSoilSourceSpecificityStreptomycesStudentsSymbiosisSystemTechnologyTestingTherapeuticTherapeutic AgentsTrainingTranscription Factor AP-1UniversitiesWisconsinWorkbaseexperiencefungusin vivo imaginginsightinterestmicrobialnext generation sequencingnovelnovel therapeuticspathogenrRNA Genessmall moleculesocialstudent trainingsuccess
中文摘要
项目总结/摘要
发现新的天然产物作为药物或药物先导物对人类具有重要意义
健康我们最近的工作已经确定,昆虫的细菌共生体代表了一个丰富的,多样的,
新化合物的未开发资源。该ICBG专注于从共生体中识别新的天然产物
在巴西,与真菌蚂蚁和其他社会昆虫有关的细菌。我们还将确定他们的
治疗真菌病原体、恰加斯病、利什曼病和血癌的潜力。在AP 3中,我们将
以多种方式促进ICBG的总体目标。我们将与AP 1密切合作,
从巴西一系列生物群落收集的昆虫细菌共生体的密集采样。菌株将
并进行了16 SrRNA测序。使用多位点序列分型,我们将检查
和菌株的宿主特异性。对于每年确定的最感兴趣的500个菌株,我们将确定
它们的次级代谢潜力以及与它们的能力相关的生态环境,
生产天然产品。为了做到这一点,我们将进行细菌共生体之间的生态分析,
真菌拮抗剂与其昆虫宿主结合,进行基因组测序和分析,并在体内进行
成像质谱最后,我们将为年轻的生物学家提供关于细菌
昆虫共生体、热带微生物生态学和生物信息学。培训将包括主办巴西
威斯康星大学麦迪逊分校的学生,以及来自美国实验室的学生在指挥领域的培训
巴西的研究。
英文摘要
PROJECT SUMMARY/ABSTRACT
Discovering novel natural products that can serve as drugs or drug leads is of critical importance to human
health. Our recent work has identified that bacterial symbionts of insects represents a rich, diverse, and largely
untapped source of novel compounds. This ICBG focuses on identifying novel natural products from symbiotic
bacteria associated with fungus-growing ants and other social insects in Brazil. We will also determine their
potential to treat fungal pathogens, Chagas disease, leishmaniasis, and cancer of the blood. In AP3, we will
contribute to the overall goals of this ICBG in a number of ways. Working closely with AP1, we will conduct
intensive sampling of bacterial symbionts from insects collected from a range of biomes in Brazil. Strains will
be catalogue and their 16S rRNA sequenced. Using multilocus sequence typing, we will examine the diversity
and host specificity of strains. For 500 strains per year identified to be of highest interest, we will determine
both their secondary metabolite potential as well as the ecological context associated with their ability to
produce natural products. To do this, we will perform ecological assays between bacterial symbionts and
fungal antagonists associate with their insect host, conduct genomic sequencing and analyses, and do in vivo
imaging mass spectrometry. Finally, we will provide training to young biologists in fieldwork on bacterial
symbionts of insects, tropical microbial ecology, and bioinformatics. Training will include hosting Brazilian
students at the University of Wisconsin-Madison, as well as training students from US labs on conducting field
research in Brazil.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of novel MDR antimicrobials from insect-Streptomyces symbioses
-
批准号:10571219
-
项目类别:
-
资助金额:$92.29万
-
财政年份:2019
-
负责人:Cameron Robert Currie
-
依托单位:
Identification of novel MDR antimicrobials from insect-Streptomyces symbioses
-
批准号:10592386
-
项目类别:
-
资助金额:$129.57万
-
财政年份:2019
-
负责人:Cameron Robert Currie
-
依托单位:
Discovery of natural product-based drugs from bacterial symbionts of insects
-
批准号:8047487
-
项目类别:
-
资助金额:$247.96万
-
财政年份:2010
-
负责人:Cameron Robert Currie
-
依托单位:
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
-
批准号:8785545
-
项目类别:
-
资助金额:$7.61万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial
-
批准号:8642727
-
项目类别:
-
资助金额:$50.36万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial
-
批准号:8836957
-
项目类别:
-
资助金额:$50.97万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
Novel therapeutic agents from the bacterial symbionts of Brazilian invertebrates
-
批准号:9335725
-
项目类别:
-
资助金额:$14.29万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
In Vitro Core
-
批准号:8836960
-
项目类别:
-
资助金额:$81.04万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
Discovering Antimicrobial Drugs from Symbiotic Actinobacteria from Terrestrial
-
批准号:9235229
-
项目类别:
-
资助金额:$55.19万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
In Vitro Core
-
批准号:9235233
-
项目类别:
-
资助金额:$65.82万
-
财政年份:--
-
负责人:Cameron Robert Currie
-
依托单位:
海外基金